SLA Pharma AG - Company Review
SLA Pharma AG - Company ReviewSummary
SLA Pharma AG (SLA Pharma) is a pharmaceutical company which develops medicines for the prevention and treatment of gastrointestinal disorders and orphan diseases. The company’s pipeline product portfolio includes topical diltiazen cream, topical metronidazole, oral eicosapentaenoic acid and oral naloxone. Its products serve the therapeutic areas such as familial adenomatous polyposis, anal fissures, perianal Crohn's disease, opioid induced constipation and faecal incontinence. SLA Pharma also conducts research and development focused on new medicines for gastrointestinal disorders. It has its operational presence in the UK and Switzerland. The company seeks to work in collaboration with pharmaceutical companies at various stages of clinical development. SLA Pharma is headquartered in Liestal, Basel, Switzerland.
This comprehensive company report of SLA Pharma AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.